<qa>  What is the purpose of the TREATMENT OF SUBJECTS WITH CRITICALEFFICACY, TOLERABILITY AND SAFETY OF INTRAMUSCULAR INJECTIONS OF PLX PAD FOR THE TREATMENT OF SUBJECTS WITH CRITICAL LIMB ISCHEMIA CLI WITH MINOR TISSUE LOSS WHO ARE UNSUITABLE FOR REVASCULARIZATION: 